Use access key #2 to skip to page content.
$13.02 -0.09 (-0.69%)
7/3/2008 1:00 PM

Momenta Pharmaceuticals, Inc. (MNTA)

CAPS Rating:
***

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

View All Commentary (MNTA)

Recs

1

Avatar TMFBreakerBrian (99.63) Submitted: 4/30/08 10:25 AM : Outperform Start Price: $15.45 MNTA Score: -6.32

It's back in the game

Report this Post Replies: 0 | Reply

Featured Broker Partners